Related by context. All words. (Click for frequent words.) 67 Gabapentin GR 66 Ophena TM 66 Bicifadine 66 TLK# 65 phase IIb clinical 65 oxymorphone ER 65 ONTAK 64 Dyloject TM 64 phase IIb study 64 ZOLINZA 64 Vilazodone 64 phase IIa clinical 64 phase IIb 64 diabetic neuropathic pain 64 brivaracetam 64 ORENCIA ® 64 forodesine 63 FIRMAGON R 63 Anturol TM 63 phase IIb trial 63 Focalin XR 63 Ventavis 63 Pivotal Phase III 63 EVIZON 63 GALNS 63 severe hypercholesterolemia 63 Phase 1b trial 63 EOquin TM 63 oral ridaforolimus 63 lintuzumab 63 opioid induced bowel dysfunction 63 Phase #b/#a trial 63 TELINTRA 63 bicifadine 63 Phenoptin 63 TBC# 63 KRN# 63 Plicera 63 Clonicel 62 MAGE A3 ASCI 62 Novolimus 62 Zenvia ™ 62 Fentanyl TAIFUN R 62 Phase IIIb clinical 62 budesonide MMX 62 AeroLEF TM 62 Phase 1a clinical 62 generation purine nucleoside 62 Zelrix 62 Elagolix 62 Raptiva ® 62 Sanctura XR 62 octreotide implant 62 alvimopan 62 Androxal TM 62 Phase 2a clinical 62 Plenaxis TM 62 LymphoStat B TM 62 subcutaneous formulation 62 orally inhaled migraine 62 Quinamed 62 oral salmon calcitonin 62 APEX PD 62 balsalazide tablet 62 reslizumab 62 OMNARIS HFA 62 phase IIb III 62 Ceflatonin 62 TELCYTA 62 BRIM3 62 oral prodrug 62 NGX# 62 Phase Ib study 62 Phase IIIb 61 cangrelor 61 Intuniv 61 cannabinor 61 phase 2a 61 RSD# oral 61 sNDA submission 61 zileuton 61 radiation sensitizer 61 LEP ETU 61 Dual Opioid 61 Zybrestat 61 Mesafem 61 methylnaltrexone 61 Luveniq 61 RSD# 61 LibiGel ® 61 Zerenex 61 CAPHOSOL 61 ALGRX 61 Targretin capsules 61 TASKi3 61 Ereska 61 alvespimycin 61 elotuzumab 61 Stedivaze 61 NVA# 61 Firazyr 61 clonidine hydrochloride 61 SILENOR 61 randomized Phase IIb 61 nalbuphine ER 61 phase IIa 61 investigational transdermal 61 investigational pan BCR 61 incyclinide 61 ponatinib 61 evaluating tivozanib 61 intranasal formulation 61 indiplon capsules 61 teriflunomide 61 PDE4 inhibitor 61 vemurafenib 61 IMA# 61 Ropinirole 61 Clolar ® 61 ruxolitinib 61 CIP TRAMADOL ER 61 DURIN TM 61 ZEGERID Capsules 61 BCX# 61 T Pred 61 proprietary transdermal patch 61 aripiprazole Abilify 61 trospium 61 treprostinil 61 Corlux 61 ONGLYZA ™ 61 tezampanel 61 registrational trial 61 GOUT 61 LAF# 61 GetGoal Phase III 60 Zytiga 60 Iloperidone 60 Zelapar 60 CoFactor 60 BiDil XR 60 neratinib 60 tanespimycin 60 INCB# [001] 60 pivotal bioequivalence 60 AZILECT R 60 Safinamide 60 guanfacine extended release 60 desvenlafaxine succinate 60 oral methylnaltrexone 60 Troxatyl 60 CRMD# 60 visilizumab 60 GAMMAGARD 60 pioglitazone HCl 60 HGS# 60 painful diabetic neuropathy 60 Capesaris 60 liprotamase 60 dalbavancin 60 photoprotective drug 60 OvaRex ® MAb 60 phase III isavuconazole 60 Evamist TM 60 ELADUR 60 Zenvia Phase III 60 EOquin 60 velaglucerase alfa 60 vorinostat 60 SEPET TM 60 Tesetaxel 60 novel histone deacetylase 60 Mipomersen 60 JZP 60 zileuton CR 60 budesonide foam 60 Cleviprex TM clevidipine 60 phase Ib 60 Phase Ib clinical 60 APTIVUS 60 Luramist 60 Bezielle 60 Phase IIB 60 orally disintegrating 60 Orazol 60 ospemifene 60 afamelanotide 60 R#/MEM 60 Exalgo 60 ACTEMRA TM 60 Probuphine 60 Initiated Phase 60 Gralise 60 icatibant 60 Drug Eluting Stent System 60 Zolpimist 60 ALVESCO HFA 60 tocilizumab 60 Tarceva TM 60 dopamine partial agonist 60 MAP# 60 Ketotransdel TM 60 alemtuzumab Campath 60 Inhalation Aerosol 60 Keppra XR 60 Fentanyl Taifun 60 corticosteroid dexamethasone 60 desvenlafaxine 60 oral treprostinil 60 fostamatinib 60 GSK# [002] 60 baminercept 60 Pivotal Phase 60 cediranib 60 candidates Dyloject TM 60 INS# [001] 60 aclidinium 60 omacetaxine mepesuccinate 60 pseudobulbar affect PBA 60 Targretin 60 NP2 Enkephalin 60 dextromethorphan quinidine 60 liposomal formulation 60 BEMA TM Fentanyl 59 TASKi2 59 Dalbavancin 59 trastuzumab DM1 T DM1 59 relapsed refractory multiple myeloma 59 phase Ib clinical 59 oral rivaroxaban 59 subcutaneously administered 59 PEG PAL 59 Toremifene 59 Q#IR 59 R#/MEM # 59 midstage clinical 59 riociguat 59 pomalidomide 59 romidepsin 59 adipiplon 59 NUVIGIL 59 Phase 2b kidney transplant 59 OMNARIS 59 Anturol 59 SPRYCEL ® 59 fosbretabulin 59 SinuNase TM 59 celgosivir 59 Cimzia ® certolizumab pegol 59 Adalimumab 59 SCENESSE ® 59 phase IIIb 59 ADVANCE PD 59 USL# 59 metoprolol succinate 59 Kamada AAT 59 BAY #-# 59 elagolix 59 Ixempra 59 Romidepsin 59 canakinumab 59 Phase IIa trial 59 NEXTERONE 59 acyclovir Lauriad R 59 Locteron ® 59 eniluracil 59 investigational protease inhibitor 59 Egrifta 59 ZACTIMA 59 DEB# 59 Tanespimycin 59 MoxDuo IR 59 Ketotransdel 59 Stavzor 59 Somatuline R Autogel R 59 Elestrin 59 LIALDA 59 Stelara 59 KNS # 59 Febuxostat 59 Omnaris 59 rasagiline tablets 59 tasocitinib 59 FOLOTYN ® 59 Phase 2b study 59 Arcalyst 59 Zoraxel 59 Aurexis 59 TOCOSOL Paclitaxel 59 Zenvia TM 59 AZILECT ® 59 Phase IIb trials 59 budiodarone 59 QVA# 59 pharmacokinetic PK study 59 Pafuramidine 59 metastatic hormone refractory 59 double blinded placebo 59 PNP inhibitor 59 rALLy 59 Phase 1b clinical 59 NitroMist TM 59 Oracea TM 59 Orally Disintegrating Tablets 59 Phase III clinical 59 cromolyn sodium 59 Xyotax 59 lasofoxifene 59 CLARITY study 59 PMA submission 59 GLP1 agonist 59 YONDELIS 59 PROMACTA 59 refractory gout 59 PREOS R 59 Aryplase 59 registrational 59 Cimzia TM 59 Zingo TM 59 enzastaurin 59 PRISTIQ 59 Phase IIb III 59 Vicriviroc 59 Phase IIb clinical trials 59 Archexin 59 investigational antiplatelet agent 59 zanolimumab 59 Phase IIb clinical 59 DUROS 59 Glumetza TM 59 Phase IIa trials 59 MERLIN TIMI 59 JAK inhibitor 59 QLT# 59 Glufosfamide 59 RhuDex 59 LEVADEX ™ 59 lomitapide 59 Inhalation Solution 59 eltrombopag 59 SUCCEED trial 59 Phase 2b clinical trials 59 Xibrom QD 59 ketoprofen patch 59 Technosphere Insulin 59 serotonin norepinephrine reuptake inhibitor 59 recurrent herpes labialis 59 Fodosine 59 interferon beta 1b 59 BrachySil TM 59 pregabalin Lyrica 59 subcutaneous methylnaltrexone 59 IIa trial 59 pivotal Phase III 59 HuMax EGFr 59 EGS# 59 Icatibant 59 lumiliximab 58 dacetuzumab 58 dirucotide 58 teduglutide 58 Phase 2b clinical 58 lapatinib Tykerb 58 vilazodone 58 Xinlay 58 AeroLEF 58 escitalopram oxalate 58 injectable diclofenac 58 docetaxel Taxotere ® 58 methylnaltrexone bromide 58 SinuNase 58 Azedra 58 ruboxistaurin 58 mipomersen 58 PrevOnco 58 Iluvien ® 58 Onrigin 58 Oracea R 58 Jevtana 58 BRIM2 58 anticancer compound 58 Proquin XR 58 ACUROX ® 58 interferon gamma 1b 58 canagliflozin 58 midstage trials 58 LY# [002] 58 Milnacipran 58 Orapred ODT 58 Voltaren Gel 58 Dapagliflozin 58 ORENCIA R 58 postoperative ileus POI 58 Huntexil 58 Fampridine 58 FM VP4 58 ER oxymorphone hydrochloride 58 hormone agonist 58 placebo controlled Phase 58 Frova ® 58 Qutenza TM 58 DEXILANT 58 cetrorelix pamoate 58 placebo controlled clinical 58 multicenter Phase 58 Onsolis 58 Denufosol 58 Golimumab 58 metaglidasen 58 docetaxel Taxotere R 58 confirmatory Phase III 58 Neupro R 58 Kynapid 58 Phase IIB clinical 58 COMFORT II 58 MOVIPREP 58 levocetirizine 58 Prostate AdenoCarcinoma Treatment 58 huC# DM4 58 Tocosol Paclitaxel 58 Bronchitol 58 PRX # 58 tafamidis 58 pioglitazone hydrochloride 58 Spiegelmer ® 58 Metformin GR 58 trastuzumab DM1 58 Cloretazine ® 58 DCCR 58 Phase III ALLEGRO 58 tolevamer 58 Frova R 58 oral taxane 58 Traficet EN 58 Pimavanserin 58 regorafenib 58 rolofylline 58 MIRCERA 58 verteporfin 58 sevelamer carbonate 58 Catena ® 58 Alvesco R 58 lintuzumab SGN 58 Degarelix 58 Besivance 58 oxypurinol 58 virus HCV protease inhibitor 58 Velac 58 etravirine 58 IND submission 58 JAK3 inhibitor 58 Phase #b/#a clinical 58 PEGINTRON TM 58 leading oral taxane 58 PHX# 58 herpetic keratitis 58 azilsartan medoxomil 58 granulated mesalamine 58 CIMZIA TM certolizumab pegol 58 EFAPROXYN 58 Phase III Pivotal 58 LUVENIQ 58 Nebido 58 sertraline Zoloft 58 aclidinium bromide 58 vildagliptin 58 ongoing Phase 1b 58 Aflibercept 58 relapsing multiple sclerosis 58 Xanafide 58 acyclovir Lauriad ® 58 mGluR5 NAM 58 bortezomib Velcade 58 PROVENGE sipuleucel T 58 atrasentan 58 DDP# 58 Panzem R NCD 58 AGILECT R 58 Hyphanox 58 Menerba 58 prGCD 58 Stalevo ® 58 POSIDUR TM 58 Vidaza azacitidine 58 Neurodex 58 Acetavance 58 pertuzumab 58 Zensana TM 58 DepoMed 58 PEP# [003] 58 Asentar 58 Onbrez Breezhaler 58 MAA submission 58 midstage studies 58 briakinumab 58 hypoxia activated prodrug 58 Tasimelteon 58 Ocrelizumab 58 vinorelbine tartrate 58 Rebif ® 58 Phase 2b trial 58 Laquinimod 58 arzoxifene 58 Cetrorelix 58 nucleotide analogue 58 mapatumumab 58 acetonide FA 58 bazedoxifene 58 Xeloda ® 58 Proellex TM 58 IL# PE#QQR 58 GRALISE 58 E1 INT TM 58 Rapaflo 58 LE SN# 58 OvaRex 58 novel oral anticoagulant 58 SUPPRELIN R LA 58 Cimzia certolizumab pegol 58 HCV protease inhibitor 58 Somatuline R Depot 58 Alocrest 58 HCl Tablets 58 EDEMA3 58 confirmatory clinical 58 Ambrisentan 58 Amrubicin 58 Phase III psoriasis 58 orBec 57 catheter occlusion 57 torezolid phosphate 57 Saforis 57 PROVENGE ® 57 ATL/TV# 57 pradefovir 57 GATTEX ® 57 Phase #b/#a 57 selective androgen receptor modulator 57 Enjuvia 57 vicriviroc 57 tiapamil 57 Pirfenidone 57 Ophena 57 6R BH4 57 HGS ETR2 57 rALLy trial 57 initiate Phase IIa 57 tezampanel NGX# 57 apomorphine hydrochloride 57 Octreotide 57 vinflunine 57 Phase 1b dose escalation 57 albiglutide 57 cetrorelix 57 ustekinumab 57 GRNVAC1 57 MGd 57 Dacogen injection 57 OncoGel 57 treat opioid induced 57 Trexima 57 prodrug stimulant 57 FUSILEV ® 57 Raptiva R 57 Saxagliptin 57 Mirapexin 57 SNT MC# 57 Prosaptide 57 Sanvar 57 EMBEDA ™ 57 Luvox CR 57 SPIRIT FIRST 57 Glycopyrrolate 57 PRIALT 57 formoterol fumarate 57 Pazopanib 57 Sular formulation 57 EDARBI 57 palifermin 57 histamine dihydrochloride 57 Orathecin 57 aleglitazar 57 Myocet 57 OraTest 57 Gelnique 57 urocortin 2 57 Cloretazine R VNP#M 57 Hedgehog antagonist 57 including eniluracil ADH 57 registrational clinical 57 CRLX# 57 Phase Ib II 57 Xcellerated T Cells 57 sublingual tablets 57 Arranon 57 Requip XL 57 Cardio Vascu Grow 57 solanezumab 57 erlotinib Tarceva 57 Certolizumab 57 Soriatane 57 Serdaxin ® 57 evaluating satraplatin 57 Indiplon 57 OSMOPREP 57 Invega 57 TEMSO 57 randomized controlled Phase 57 Levitra vardenafil 57 GW# [003] 57 Ozarelix 57 TRANSDUR ™ 57 MyVax R 57 Bifeprunox 57 ORAL Sync 57 Focalin XR ® 57 dextofisopam 57 Phase IIa 57 ULTRASE 57 JANUVIA 57 Omacetaxine 57 Amigal 57 DAYTRANA TM 57 Phase IIb Trial 57 hydrochloride tablets 57 BEMA Buprenorphine 57 ONCONASE R 57 ISENTRESS 57 Omnitarg 57 zafirlukast 57 Emezine 57 Tekamlo 57 Initiates Phase III 57 LymphoStat B belimumab 57 TG# [003] 57 vidofludimus 57 successfully commercialize Iluvien 57 CDP# 57 CHAMPION PCI 57 investigational compound 57 ABILIFY ® 57 IPX# 57 Phase IIa clinical 57 sorafenib Nexavar 57 Memryte 57 PrevOnco ™ 57 Intervention Effectiveness 57 Allovectin 7 57 REMOXY R 57 TRANSDUR Sufentanil 57 ALVESCO ® 57 Phase III placebo controlled 57 Zemplar Capsules 57 GLP toxicology studies 57 receptor tyrosine kinase inhibitor 57 ancrod 57 Nasulin 57 mesylate tablets 57 methylphenidate transdermal system 57 avanafil 57 CA9 SCAN 57 AMEVIVE 57 Marketing Authorisation Application 57 SAPHRIS 57 Solorel 57 Phase 2a 57 Femara letrozole 57 ralfinamide 57 Omigard 57 NeuroSTAT ® 57 AGGRASTAT R Injection tirofiban 57 sapacitabine 57 Amrix 57 tolterodine 57 LUMINATE 57 PFO migraine 57 Latuda 57 EMBEDA 57 ocular formulation 57 Phase III Clinical Trial 57 ImClone Erbitux 57 eosinophilic asthma 57 Bicalutamide 57 Tyrima 57 MEND CABG 57 Lialda 57 Telcyta 57 febuxostat 57 Indomethacin 57 FACTIVE R gemifloxacin 57 Hsp# inhibitor 57 rALLy clinical trial 57 cilengitide 57 HCV RESPOND 2 57 DPP4 inhibitor 57 brand ciclesonide HFA 57 ITAX 57 topiramate Topamax 57 belinostat 57 Genz # 57 MedTone 57 Adcirca 57 EXPAREL ™ 57 Phase 2a trial 57 Phase IIb trial 57 LymphoStat B 57 efficacy endpoint 57 prucalopride 57 AEG# 57 ulimorelin 57 AEGR 57 unresectable malignant mesothelioma UMM 57 Velcade bortezomib 57 Targeted Chemotherapy 57 EVIZON TM 57 LCP AtorFen 57 ezogabine 57 TM Drug Eluting 57 Afatinib 57 ICA # 57 SAR# [004] 57 ILUVIEN ® 57 custirsen 57 RoACTEMRA 57 assessing T DM1 57 Pagoclone 57 ELND# 57 GEM OS2 57 CLORETAZINE TM VNP#M 57 Bepreve 57 REMINYL ® 57 torsemide ER 57 Cloretazine 57 cell lymphoma CTCL 57 Sym# 57 candidate XP# 57 Certolizumab pegol 57 dual endothelin receptor antagonist 57 ZYFLO CR 57 EpiCeram 57 Nuvion 57 VELCADE melphalan 57 cetuximab Erbitux 57 BEMA TM LA 57 PRT# 57 Desmoteplase 57 tarenflurbil 57 Eli Lilly Cymbalta 57 Oravig 57 Zorbtive TM 57 galiximab 57 Atelvia 57 HGS ETR1 57 octreotide acetate 57 multicenter Phase III 57 ThermoDox R 57 NEBIDO 57 ganetespib 57 ToGA 57 AzaSite Plus 57 novel VDA molecule 57 fidaxomicin Phase 3 57 ostarine 57 Synavive 57 synthetic retinoid 57 mg/m2 cohort 57 Diabetic Macular Edema DME 57 Proquin 56 Onco TCS 56 Duromist ™ 56 BrachySil 56 gefitinib Iressa 56 Investigational Oral 56 MIST II 56 oral transmucosal 56 randomized blinded 56 investigational monoclonal antibody 56 #I TM# 56 telomerase therapeutic 56 Viveta 56 iloperidone 56 selegiline 56 Itopride 56 quetiapine fumarate 56 BENICAR HCT 56 XL# SAR# 56 supplemental biologics 56 Abstral 56 ELADUR ™ 56 maximally tolerated dose 56 registrational Phase 56 Flector Patch 56 Initiate Phase 56 Urocortin 2 56 MONOVISC 56 multidose 56 squalamine 56 VEGF Trap 56 Phase III randomized controlled 56 Xibrom TM 56 Contrave# 56 abiraterone acetate 56 Levadex 56 MKC# MT 56 Genasense ® oblimersen 56 Avanafil 56 Actimmune ® 56 PEARL SC 56 overactive bladder AA# 56 HuMax CD4 56 PREOS 56 Lu AA# 56 MEND CABG II 56 HuLuc# 56 Emselex 56 ILLUMINATE 56 tasimelteon 56 refractory chronic lymphocytic 56 FOLFOX6 chemotherapy regimen 56 Azedra TM 56 Temsirolimus 56 OvaRex R 56 cyclobenzaprine hydrochloride extended 56 Romiplostim 56 ularitide 56 oral formulation 56 evaluating Xcytrin 56 histone deacetylase HDAC inhibitor 56 Initiate Clinical Trial 56 Polyphenon ® E 56 rhThrombin 56 AVADO 56 Glybera 56 ChronVac C R 56 LIVALO 56 HCD# [002] 56 HuMax CD# 56 Benlysta belimumab 56 Phase Ib 56 SinuNase ™ 56 AVERROES 56 SUMAVEL 56 tecarfarin 56 Premarket Approval PMA 56 PRE SURGE 56 DR Cysteamine 56 Vertex hepatitis C 56 Brovana 56 dose escalation Phase 56 Dendreon Provenge 56 risedronate sodium tablets 56 AZILECT 56 crizotinib PF # 56 ATL# [001] 56 initiated Phase Ib 56 Ziprasidone 56 drug eluting stent DES 56 REVLIMID lenalidomide 56 confirmatory Phase 3 56 etanercept Enbrel 56 Darusentan 56 PREGNANT Study 56 ZoMaxx 56 NDA resubmission 56 Nexavar sorafenib 56 crofelemer 56 BLP# Liposome Vaccine 56 MYDICAR 56 vascular disrupting agent 56 Personalized Immunotherapy 56 VersaFilm 56 Peginterferon alfa 2b 56 multicenter Phase II 56 Alfimeprase 56 paliperidone palmitate 56 ixabepilone 56 diclofenac sodium 56 PENNSAID 56 Onalta ™ 56 fluocinolone acetonide 56 rNAPc2 56 PRIMO CABG 56 goserelin 56 INKP 56 ENTEREG 56 Soliris TM eculizumab 56 HoFH 56 MKC# MKC# PP 56 cutaneous T 56 diarrhea predominant irritable 56 Valtropin 56 CANCIDAS 56 Afrezza 56 Sprycel dasatinib 56 Phase Ib IIa 56 Phase III confirmatory 56 epoetin alpha 56 Aliskiren 56 PSMA ADC 56 Zolinza 56 targeted radiotherapeutic 56 LY# [003] 56 Fenoglide 56 deforolimus 56 Phase III 56 Adlea 56 vernakalant hydrochloride 56 hour bronchodilation 56 Panzem R 56 OLEPTRO ™ 56 OMS#HP 56 pegloticase 56 XIBROM 56 Indaflex TM 56 INCB# [002] 56 PEGylated interferon 56 Phase IIb 56 BAL# [002] 56 Amlodipine Besylate 56 recurrent glioblastoma 56 TAXUS Element Stent System 56 candidate Zenvia 56 somatostatin analog 56 EpiCept NP 1 56 IV APAP 56 initiate Phase 2b 56 hepatitis C protease inhibitor 56 Meets Primary Endpoint 56 Telintra 56 RSR# 56 INCIVEK 56 RELOVAIR ™ 56 Trobalt 56 BLA filing 56 VNP#M 56 Galantamine 56 PEGylated Fab fragment 56 LEUKINE 56 docetaxel chemotherapy 56 Xolegel 56 DepoDur 56 ENDEAVOR III 56 secondary efficacy endpoints 56 VPRIV 56 pralatrexate injection 56 zolmitriptan 56 UCB Cimzia 56 abatacept 56 APF# Phase 56 Preotact 56 FDA approvable letter 56 sunitinib malate 56 Fortigel 56 candidate AQ4N 56 vandetanib 56 lixisenatide 56 ribavirin Copegus ® 56 Onconase 56 INT# [002] 56 Yervoy 56 Amplimexon 56 placebo controlled Phase III 56 XOPENEX 56 gemifloxacin 56 alfa 2a 56 velafermin 56 drug eluting coronary stent 56 bevacizumab Avastin 56 Phase III ADT 56 asenapine 56 CYCLOSET 56 indacaterol 56 thalidomide Thalomid 56 Tolvaptan 56 morphine sulfate extended 56 Emend 56 SILENOR TM 56 PDX pralatrexate 56 VEGF inhibitor 56 thymalfasin 56 topical formulation 56 treatment naive genotype 56 PTH1 56 Pemetrexed 56 Abilify aripiprazole 56 Phase 2b Clinical Trial 56 oral deforolimus 56 Relistor 56 Fulvestrant 56 efalizumab 56 fenofibric acid 56 Actilon 56 Daytrana ® 56 alogliptin 56 ZEVALIN ® 56 NATRECOR R 56 rhIGF-I/rhIGFBP-3 56 TRANSFORMS 56 estradiol transdermal spray